1. Home
  2. PSTV vs CAPS Comparison

PSTV vs CAPS Comparison

Compare PSTV & CAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • CAPS
  • Stock Information
  • Founded
  • PSTV 1996
  • CAPS 1987
  • Country
  • PSTV United States
  • CAPS United States
  • Employees
  • PSTV N/A
  • CAPS N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • CAPS
  • Sector
  • PSTV Health Care
  • CAPS
  • Exchange
  • PSTV Nasdaq
  • CAPS NYSE
  • Market Cap
  • PSTV 10.4M
  • CAPS 9.8M
  • IPO Year
  • PSTV N/A
  • CAPS N/A
  • Fundamental
  • Price
  • PSTV $0.31
  • CAPS $1.42
  • Analyst Decision
  • PSTV Strong Buy
  • CAPS
  • Analyst Count
  • PSTV 3
  • CAPS 0
  • Target Price
  • PSTV $10.83
  • CAPS N/A
  • AVG Volume (30 Days)
  • PSTV 59.8M
  • CAPS 70.8K
  • Earning Date
  • PSTV 08-13-2025
  • CAPS 04-02-2025
  • Dividend Yield
  • PSTV N/A
  • CAPS N/A
  • EPS Growth
  • PSTV N/A
  • CAPS N/A
  • EPS
  • PSTV N/A
  • CAPS N/A
  • Revenue
  • PSTV $5,206,000.00
  • CAPS $43,416,000.00
  • Revenue This Year
  • PSTV $13.26
  • CAPS $7.87
  • Revenue Next Year
  • PSTV $8.84
  • CAPS N/A
  • P/E Ratio
  • PSTV N/A
  • CAPS N/A
  • Revenue Growth
  • PSTV N/A
  • CAPS N/A
  • 52 Week Low
  • PSTV $0.16
  • CAPS $1.40
  • 52 Week High
  • PSTV $2.31
  • CAPS $16.18
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 46.79
  • CAPS N/A
  • Support Level
  • PSTV $0.30
  • CAPS N/A
  • Resistance Level
  • PSTV $0.37
  • CAPS N/A
  • Average True Range (ATR)
  • PSTV 0.05
  • CAPS 0.00
  • MACD
  • PSTV 0.02
  • CAPS 0.00
  • Stochastic Oscillator
  • PSTV 53.61
  • CAPS 0.00

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About CAPS CAPSTONE HOLDING CORP

Capstone Holding Corp is a building products distribution network. The existing network is comprised of Instone, a distributor of thin veneer stone and related masonry products in the United States, serving both residential and commercial construction markets. The company's product offering includes manufactured and natural stone products, supported by a distribution network. The company's current products include stone veneer, landscape stone, and modular masonry fireplaces.

Share on Social Networks: